Eligibility Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module

Ignite Creation Date: 2025-12-25 @ 3:48 AM
Ignite Modification Date: 2025-12-25 @ 3:48 AM
NCT ID: NCT01668602
Eligibility Criteria: Inclusion Criteria: * Chronic stroke (\>6 months post stroke) * First (single) lesion * Able to walk with or without the use of a cane or walker * Sufficient cardiovascular health and ankle stability to walk for 6 minutes at a self-selected speed without an orthoses * Resting heart rate 40-100 beats per minute * Resting blood pressure between 90/60-70/90 Exclusion Criteria: * Evidence of moderate/ severe chronic white matter disease or cerebellar stroke on MRI * Cerebellar signs (ataxic ("drunken") gait or decreased coordination during rapid alternating hand or foot movements * Insulin dependent diabetes * History of lower extremity joint replacement * Score of \>1 on question 1b and \>0 on question 1c on NIH Stroke Scale * Inability to communicate with investigators * Neglect/hemianopia, or unexplained dizziness in last 6 months * Neurologic conditions other than stroke * Orthopedic problems in the lower limbs or spine (or other medical conditions) that limit walking * Contraindications to transcranial magnetic stimulation (TMS) are: history of seizures, metal implants in the head or face, history of recurring or severe headaches/migraine, headache within the past 24 hours, presence of skull abnormalities or fractures, hemorrhagic stroke, history of dizziness, syncope, nausea, or loss of consciousness in the past 12 months
Healthy Volunteers: False
Sex: ALL
Minimum Age: 30 Years
Maximum Age: 80 Years
Study: NCT01668602
Study Brief:
Protocol Section: NCT01668602